Multiple Myeloma
Showing NaN - NaN of 114
Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)
Recruiting
- Multiple Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Atlanta, Georgia
- +1 more
Feb 25, 2022
Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)
Completed
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- Dexamethasone
-
Whittier, California
- +19 more
Feb 2, 2022
Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)
Completed
- Multiple Myeloma
- Lenalidomide
- lenalidomide, bortezomib and dexamethasone
-
Tucson, Arizona
- +53 more
Dec 8, 2021
Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)
Terminated
- Multiple Myeloma
- Waldenstrom Macroglobulinemia
-
Scottsdale, Arizona
- +18 more
Nov 15, 2021
Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)
Recruiting
- Myeloma
- Multiple Myeloma
- Daratumumab
- +3 more
-
Chicago, IllinoisThe University of Chicago
Sep 15, 2021
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active, not recruiting
- Acute Leukemia
- +3 more
- cytogenetic analysis
-
La Jolla, California
- +136 more
Aug 16, 2021
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who
Recruiting
- Multiple Myeloma
- +3 more
- EndoPAT
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Jun 7, 2021
Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Carfilzomib
- +3 more
-
Chicago, IllinoisUniversity Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021
Multiple Myeloma Trial in United States (bb21217)
Active, not recruiting
- Multiple Myeloma
- bb21217
-
San Francisco, California
- +10 more
Mar 17, 2021
Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin
Completed
- Leukemia
- +3 more
- Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
- +4 more
-
Chicago, IllinoisThe University of Chicago
Jan 8, 2021
Connect® MM- The Multiple Myeloma Disease Registry
Active, not recruiting
- Multiple Myeloma
-
Huntsville, Alabama
- +252 more
Jan 21, 2021
Multiple Myeloma Trial in Chicago (Screening Phase, Discontinuation Phase)
Recruiting
- Multiple Myeloma
- Screening Phase
- Discontinuation Phase
-
Chicago, IllinoisUniversity Of Chicago Medicine Comprehensive Cancer Center
Jan 8, 2021
Multiple Myeloma, Renal Insufficiency Trial in Spain, United Kingdom, United States (BHQ880, BHQ880 Placebo, bortezomib)
Completed
- Multiple Myeloma
- Renal Insufficiency
- BHQ880
- +3 more
-
Chicago, Illinois
- +7 more
Dec 11, 2020